AAV-Dkk1 Gene Therapy Agent

Improves lung compliance

An adeno-associated virus vector-based gene therapy agent that delivers the Dkk1 gene to simultaneously inhibit Wnt/β-catenin signaling and oxidative stress, alleviating silicotic lesions and improving lung function, offering an alternative to adenoviral vectors for silicosis treatment.

Ma, Jia · Wang, Jiaqi · Sun, Ruiting · Zhaojun, Wang · Xue, Jing · Wu, Shuang · Hu, Wenfeng · Wang, Jing · Cai, Qian · Chen, Juan · Liu, Xiaoming

Antioxidants and Redox Signaling 2024

Advantages

Alleviation of silicotic lesions

Improvement of pulmonary compliance

Improvement of radiological findings